Home Blog Page 287

Investor Pointe Names Manfredi Bargioni Chief Client Officer

By
Advertorial Desk
-

Untap co-founder will lead expanded client success and services teams as the company deepens its focus on client outcomes across private markets.

London, United Kingdom – Newsfile Corp. – July 29, 2026 – Investor Pointe, a global technology and services firm powering how private markets firms operate, today announced the appointment of Manfredi Bargioni as Chief Client Officer. Bargioni will lead Investor Pointe’s client success and services teams. The appointment reflects the company’s approach of providing human expertise and agentic technology at the level each organisation requires.

A co-founder of Untap, which is now part of Investor Pointe, Bargioni brings more than 20 years of experience in financial services and business development, including senior leadership roles at Citigroup and UBS, as well as serving as COO of Hydra Management. His teams help private markets investment managers, wealth managers, advisors, and fund administrators realise the full value of their technology, operations, and data. He will oversee clients globally and is based in the company’s London office.

Drawing on Bargioni’s experience across firms of varying sizes, technology demands, and data maturity, the expanded function provides clients with local expertise supported by a multijurisdictional technology platform. The function is centred around regional leaders: Harriet Barlow and Olivia Gibson in EMEA, Claudia Madriaga in South America, Max Fenn in APAC, and Jay Shows in North America. Their teams assist clients with a full range of services spanning the firm’s solutions, with specialists in account management, investor servicing, and implementation.

“For us, client success encompasses the entire relationship: the product roadmap, the services we provide, and the challenges we address together,” said Bargioni. “We want every client to realise the full value of their technology and, above all, their data. Their success is our success, and we see ourselves as an extension of their team. Self-service, co-managed, or fully managed, we handle as much of fund operations, investor relations, and data workflows as they want us to, so their people stay focused on relationships and returns.”

“Private markets firms are facing rising investor demand for real-time reporting and transparency, even as much of the industry’s data still lives in spreadsheets and disconnected systems,” said Scott Hofmann, Investor Pointe CEO. “Our model combines AI-powered technology with a dedicated services team so firms can close that gap without having to develop the capability in-house. Client success has been a key differentiator for us from the start, and this new role reflects that. Manfredi’s extensive experience, closely aligned with how private markets firms actually operate, provides the perspective we need to achieve positive client outcomes, and that’s why he’s the right person for the job as we grow.”

About Investor Pointe: Investor Pointe is a global technology and services firm powering how private markets firms operate. It unites distribution, investor engagement, portfolio management, and the underlying data layers into a single, secure system. As a partner from initial product decisions to the final capital return, Investor Pointe’s agentic solution is supported by a team of human experts to provide clients with exactly the level of support they need, from self-serve to fully managed. Investor Pointe has over 2,500 funds managed on its system, working with leading investment managers, wealth managers, fund administrators, and advisors with over $400 billion in assets. Investor Pointe has offices in London, New York, Hong Kong, Hyderabad, and Bogotá. For more information, visit www.investorpointe.com.

Press Contact:
Margarita Kouklaki Ntourou
Communications Manager, Investor Pointe
margarita.kouklakintourou@investorpointe.com

The issuer is solely responsible for the content of this announcement.

Pacific Century Premium Developments Limited announces interim results for six months ended June 30, 2026

By
Advertorial Desk
-

HONG KONG SAR – Media OutReach Newswire – 29 July 2026

2026 Interim Results – Financial Highlights

(Figures for the corresponding period in 2025 are shown in brackets)

  • Consolidated revenue: HK$593 million (HK$ 636 million)
  • Consolidated net loss attributable to equity holders of the Company: HK$189 million (HK$ 249 million)
  • Basic loss per share: 9.28 HK cents (12.23 HK cents)
  • No interim dividend (No interim dividend)

Pacific Century Premium Developments Limited (“PCPD”, SEHK: 00432) announced its interim results for the six months ended June 30, 2026.

The consolidated revenue of PCPD and its subsidiaries (together, the “Group”) amounted to HK$ 593 million, compared to HK$ 636 million for the corresponding period of 2025.

The Group’s consolidated loss attributable to equity holders of the Company for the first six months of 2026 totalled HK$ 189 million, compared to a net loss of HK$249 million for the corresponding period last year. Basic loss per share for the six months ended June 30, 2026 was 9.28 Hong Kong cents, compared to a loss per share of 12.23 Hong Kong cents for the corresponding period of 2025.

The Board of Directors did not declare an interim dividend for the first half of 2026.

For the first half of 2026, the Group delivered encouraging results as we built on our core strengths and benefited from resilient demand across the markets in which we operate. During the period, we also took steps to enhance our portfolio, including the disposals of two investment assets. These initiatives are expected to strengthen the Group’s financial position and reinforce its long-term growth.

Our operations in Japan performed well despite some moderation in tourism demand, shaped by changes in the composition of international visitors and fluctuations in travel demand. Park Hyatt Niseko, Hanazono, our hospitality business in Niseko, Hokkaido, delivered a stable performance with healthy occupancy and room rates, while our ski operations remained a key contributor to the Group’s results. Earnings from our recreational facilities, ski lifts, equipment rentals, “Hanazono EDGE” (a restaurant and entertainment centre) and Niseko International Snowsports Schoolcontinued togrow year-on-year. We will stay focused on establishing Niseko Hanazono Resort as a world-class, all-season luxury destination and remain optimistic about its long-term development.

On March 16, 2026, the Group announced the sale of its entire interest in Pacific Century Place, Jakarta (“PCP Jakarta”) in Indonesia. The transaction, at a total consideration of US$400 million, was completed on June 8, 2026. Notwithstanding the disposal, the Group will continue to provide property management services in respect of PCP Jakarta.

On February 13, 2026, the Group announced the sale of its entire interest in Midtown Niseko. The transaction, at a total consideration of US$80 million, was completed on May 31, 2026.

The Group formed a strategic alliance with Hotel Properties Limited in Singapore to bring a Four Seasons Resort and Branded Residences to Aquella, a large-scale integrated resort development in Phang Nga. The move represents a significant milestone in PCPD‘s long-term vision of transforming Aquella into an integrated resort destination that effortlessly blends luxury living, recreation and exceptional service.

Central Residence by the Park in Hong Kong was launched for sale in January 2026. As at the end of June, 90.9% of the total available units of the luxury residential project had already been sold. The project will be completed in the latter half of 2026.

Mr. Benjamin Lam, PCPD’s Deputy Chairman and Group Managing Director, said: “The first half of 2026 presented a challenging global environment, characterised by geopolitical tensions including the conflict in the Middle East, inflation, trade uncertainties and concerns over monetary policies. Despite the headwinds, global growth was relatively resilient, while international tourism in many parts of Asia continued to perform steadily. The Group’s core markets in Asia generally remained solid during the period. Tourism demand continued to support Japan and Thailand despite a slightly more measured pace of growth. Improving sentiment in Hong Kong’s property market also provided a more favourable backdrop for our luxury residential development.

In the second half of the year, we will continue to enhance the value of our existing assets while positioning the Group to capitalise on opportunities that support our long-term strategy and create value for our stakeholders.”

Hashtag: #PacificCenturyPremiumDevelopments

The issuer is solely responsible for the content of this announcement.

About PCPD

Pacific Century Premium Developments Limited (“PCPD” or the “Group”, SEHK: 00432) is principally engaged in the development and management of premium-grade property and infrastructure projects as well as premium-grade property investments. PCCW Limited (“PCCW”, SEHK: 00008) is the single largest shareholder of the Group.

SEMI Reports Worldwide Silicon Wafer Shipments Increase 7.4% Year-on-Year in Q2 2026

By
Advertorial Desk
-

Growth in Global Silicon Wafer Shipments Driven by AI Demand as Industrial and Automotive Markets Show Signs of Recovery

MILPITAS, Calif., July 29, 2026 /PRNewswire/ — The SEMI Silicon Manufacturers Group (SMG) reported today, in its quarterly analysis of the silicon wafer industry, that worldwide silicon wafer shipments increased 7.4% year-on-year to 3,573 million square inches (MSI) from the 3,327 MSI recorded during the same quarter of 2025. Shipments increased 9.1% quarter-over-quarter from the 3,275 MSI recorded during the first quarter of 2026.

Worldwide Silicon Wafer Shipments
Worldwide Silicon Wafer Shipments

“Silicon wafer shipments maintained steady growth in the second quarter, driven by strong and increasing AI-related demand beyond advanced logic and memory to include power devices, photonics, and other markets,” said Ginji Yada, Chairman of SEMI SMG and Managing Executive Officer, General Manager, Sales and Marketing Division at SUMCO Corporation. “In addition, industrial and automotive demand is recovering, while memory price pressures are contributing to constrained PC and smartphone demand. Device manufacturers are investing heavily in capacity expansion, and silicon wafer demand growth is expected to continue.”

Silicon wafers are the fundamental building material for the majority of semiconductors, which are vital components of all electronic devices. The highly engineered thin disks are produced in diameters of up to 300 mm and serve as the substrate material on which most semiconductors are fabricated.

The SMG is a sub-committee of the SEMI Electronic Materials Group (EMG) and is open to SEMI members involved in manufacturing polycrystalline silicon, monocrystalline silicon or silicon wafers (e.g., as cut, polished, epitaxial). The SMG facilitates collective efforts on issues related to the silicon industry, including the development of statistics about the silicon industry.

For more information, visit SEMI Worldwide Silicon Wafer Shipment Statistics.

Follow SEMI Market Intelligence

Follow SEMI 

About SEMI

SEMI® is the global industry association connecting over 4,000 companies and 1.5 million professionals worldwide across the semiconductor and electronics design and manufacturing supply chain. We accelerate member collaboration on solutions to top industry challenges through Advocacy, Workforce Development, Sustainability, Supply Chain Management and other programs. Our SEMICON® expositions and events, technology communities, standards and market intelligence help advance our members’ business growth and innovations in design, devices, equipment, materials, services and software, enabling smarter, faster, more secure electronics. Visit www.semi.org, contact a regional office, and connect with SEMI on LinkedIn and X to learn more.

Association Contacts
Sherrie Gutierrez/SEMI
Phone: 1-831-889-3800
Email: sgutierrez@semi.org

Lisa Gillette-Martin/Bodewell Group (Media Inquiries)
Phone: 1-408-205-4732
Email: lgmartin@bodewellgroup.com   

SEMI® is the global industry association connecting over 4,000 companies and 1.5 million professionals worldwide across the semiconductor and electronics design and manufacturing supply chain. We accelerate member collaboration on solutions to top industry challenges through Advocacy, Workforce Development, Sustainability, Supply Chain Management and other programs. Our SEMICON® expositions and events, technology communities, standards and market intelligence help advance our members’ business growth and innovations in design, devices, equipment, materials, services and software, enabling smarter, faster, more secure electronics. Visit www.semi.org to learn more.
SEMI® is the global industry association connecting over 4,000 companies and 1.5 million professionals worldwide across the semiconductor and electronics design and manufacturing supply chain. We accelerate member collaboration on solutions to top industry challenges through Advocacy, Workforce Development, Sustainability, Supply Chain Management and other programs. Our SEMICON® expositions and events, technology communities, standards and market intelligence help advance our members’ business growth and innovations in design, devices, equipment, materials, services and software, enabling smarter, faster, more secure electronics. Visit www.semi.org to learn more.

COSRX secures multiple top-five Amazon rankings during Prime Day 2026

By
Advertorial Desk
-

NEW YORK, July 29, 2026 /PRNewswire/ — COSRX, the global derma skincare brand known for its essentials-only approach, announced today that it secured five top-five category placements on Amazon U.S. during Prime Day 2026, held from June 23 through June 26. Leading the impressive results, the Low pH Good Morning Gel Cleanser ranked No. 1 in Facial Cleansing Gels, while established icons and newer launches across facial serums, toners, eye masks and facial masks also rose to the top of their categories – showcasing the strength of the wider COSRX skincare lineup.

To explore the brand’s high-performance, results-driven skincare solutions, visit the official COSRX store on Amazon U.S.

COSRX secures multiple top-five Amazon rankings during Prime Day 2026
COSRX secures multiple top-five Amazon rankings during Prime Day 2026

Top-Performing COSRX Skincare Products on Prime Day 2026

Award-Winning Cleansers: Low pH Gel Tops Amazon Charts

The COSRX Low pH Good Morning Gel Cleanser led the brand’s Prime Day performance, reaching No. 1 in Amazon U.S.’s Facial Cleansing Gels category. Its lightweight gel formula washes away oil, sweat and daily impurities without leaving the skin feeling overly dry or tight. Because its low-pH formula is closer to the skin’s natural level, it provides a gentle, refreshing cleanse that fits easily into every day and sensitive-skincare routines. Frequently featured in K-beauty starter guides and must-buy lists, the cleanser has become a trusted introduction to Korean skincare as well as a longtime staple for users. With approximately 20,000 Amazon reviews and an average rating of 4.5 out of five stars, it remains one of COSRX’s most recognized and widely loved products.

Complementing the bestselling gel cleanser, the newer COSRX Red Rice Inositol Pore Clarifying Deep Cleanser recorded its highest sales volume since launch during Prime Day. Developed for clogged pores, blackheads, excess oil and rough texture, its dense, cushiony formula glides over the skin with a balm-like feel before transforming into a soft foam with water.

Together, the two cleansers offer a flexible AM-to-PM routine: a lightweight, low-pH gel for gentle daily cleansing and a richer pore cleanser when skin needs a more thorough reset.

Advanced Peptide Skincare for Anti-Aging and Radiance

COSRX’s Peptide-powered products delivered strong Prime Day results across both eye care and facial skincare. The Peptide Collagen Hydrogel Eye Patch ranked No. 2 in Amazon’s Eye Masks category, reinforcing its popularity as a viral TikTok favorite for visible puffiness, fine lines and loss of firmness. The cooling hydrogel patches combine peptides and collagen in an easy-to-use format that fits naturally into morning preparation or an evening self-care routine.

COSRX’s The 6 Peptide Skin Booster Serum also reached No. 2 in Amazon’s Facial Toners & Astringents category. The serum is a lightweight first-step booster with a toner-like texture, designed to prepare the skin for the products that follow while improving the look of texture, elasticity and radiance.

It was joined by the newly launched dermatologist-recommended Blue Peptide Bakuchiol Plump Glow Serum, which pairs naturally blue Copper Peptides (GHK-Cu) with the gentler Retinol-alternative Bakuchiol to help simultaneously plump, lift and refine the skin.

K-Beauty Staples: Snail Mucin and PDRN Formulas Dominate

Beyond Peptides, COSRX’s strength in clinically inspired, ingredient-led skincare was also reflected in the strong Prime Day performance of its Snail Mucin and PDRN formulas.

The Advanced Snail 96 Mucin Power Essence ranked No. 2 in Facial Serums and No. 25 across Amazon U.S. Beauty & Personal Care. Widely recognized as an original K-beauty icon, the essence has become a fixture on Amazon beauty must-buy lists, particularly during major deal events.

Its fast-absorbing Snail Mucin formula delivers lightweight hydration while helping support the skin barrier and calm the look of stressed, sun-exposed skin. The non-heavy texture makes it especially appealing during summer, leaving skin looking smoother, refreshed and luminous.

The PDRN EXOSOME Skinplaning Glaze Mask rounded out the rankings at No. 5 in Amazon’s Facial Masks category. The pearlescent Korean wrapping mask forms a luminous glaze as it dries, delivering intensive hydration and elasticity care before peeling away to reveal a smoother, more radiant-looking finish. With its PDRN-focused formula, eye-catching sheen and easy peel-off format, it offers an elevated at-home option for hydrated, glossy, glass-skin results.

About COSRX

Rooted in science and driven by results, COSRX is a global derma skincare brand known for its high-performance yet affordable formulations that target real skin concerns with minimal ingredients and maximum efficacy. Trusted by skincare lovers worldwide, COSRX delivers visible results through carefully selected actives in concentrated doses. Discover its award-winning lineup at retailers including COSRX.com, Amazon, ULTA, Revolve, Dermstore, Nordstrom and Target. Follow @cosrx on Instagram and TikTok for the latest product drops, tips, and trends.

Ractigen Therapeutics Closes Over $31 Million Financing to Advance Clinical-Stage saRNA Pipeline and Proprietary Extrahepatic Delivery Platforms

By
Advertorial Desk
-

Funding led by Guozhong Capital will accelerate Phase 2 development for saRNA candidate RAG-01 and CNS asset RAG-17, advance systemic saRNA program RAG-18 toward IND, and expand extrahepatic RNA delivery technologies.

NANTONG, China, July 29, 2026 /PRNewswire/ — Ractigen Therapeutics, a clinical-stage biotechnology company pioneering small activating RNA (saRNA) therapeutics and advanced extrahepatic delivery systems, today announced the successful closing of a new financing round exceeding $31 million (over RMB 200 million).

The round was led by Guozhong Capital, with participation from IDG Capital, China Everbright Limited, Jolmo Capital, Win-Win Capital, and SND Financial Holdings. Existing shareholder Longmen Capital participated for its third consecutive round.

Proceeds will primarily accelerate the clinical development of Ractigen’s saRNA assets and validate its proprietary extrahepatic delivery platforms. Key priorities include:

  • Advancing lead saRNA oncology program (RAG-01): Accelerating Phase 2 clinical trials in non-muscle-invasive bladder cancer (NMIBC) following positive clinical proof-of-concept and U.S. FDA Fast Track Designation.
  • Driving systemic saRNA asset toward IND (RAG-18): Advancing ongoing investigator-initiated trials (IIT) and preparing for IND filing for Duchenne muscular dystrophy (DMD).
  • Progressing CNS clinical asset (RAG-17): Moving forward with Phase 2 clinical trials in amyotrophic lateral sclerosis (ALS) following Phase 1 safety and biomarker validation published in Nature Medicine.
  • Expanding extrahepatic delivery platforms: Continuously enhancing the company’s proprietary SCAD™ (CNS) and LiCO™ (systemic multi-tissue) delivery technologies to unlock new therapeutic targets outside the liver.

Pioneering saRNA Technology: Unlocking Gene Activation for Unmet Needs

Oligonucleotide therapeutics represent the third major wave of biopharmaceutical innovation following small molecules and monoclonal antibodies. However, traditional RNA therapeutics have been largely limited to gene-silencing approaches (siRNA and ASO).

As the global pioneer in RNA activation (RNAa), Ractigen was founded to redefine genetic medicine by enabling precise gene activation. Discovered by Ractigen’s founder, RNAa utilizes saRNAs targeting gene promoter regions to upregulate endogenous protein expression at the transcriptional level without altering the genome. This unique mechanism unlocks previously undruggable therapeutic targets, expanding treatment possibilities across genetic disorders, haploinsufficiencies, cancer, and metabolic diseases.

Breaching Extrahepatic Barriers: Proprietary Delivery Systems

To deliver saRNA and targeted oligonucleotide payloads beyond the liver, Ractigen engineered two complementary, carrier-free delivery platforms:

  • SCAD™ (CNS delivery platform): Utilizes an accessory oligonucleotide (ACO)-enabled self-delivery mechanism to cross central nervous system barriers, achieving clinical proof-of-concept for safety and target engagement via RAG-17.
  • LiCO™ (Systemic multi-tissue platform): Conjugates specialized lipids to oligonucleotides via proprietary SDL™ linkers. LiCO™ enables durable, carrier-free delivery to muscle, heart, bladder, and eye tissues, sustaining therapeutic activity for up to nine months per single administration with simplified, cost-effective manufacturing.

Clinical & Commercial Momentum

Ractigen has successfully translated its saRNA and extrahepatic delivery technologies into three differentiated clinical-stage assets:

  • RAG-01: The world’s first conjugate-delivered saRNA therapeutic to demonstrate clinical proof-of-concept in oncology. In Phase 1 trials, RAG-01 achieved a preliminary any-time 67% complete response (CR) rate in BCG-unresponsive high-risk NMIBC patients.
  • RAG-18: The world’s first saRNA program targeting Duchenne muscular dystrophy (DMD) and a major milestone in breaching extrahepatic muscle delivery barriers. Currently in investigator-initiated trials (IIT), RAG-18 delivers saRNA systemically to upregulate Utrophin expression, demonstrating clear target engagement, marked biomarker reductions, and histopathological improvements in muscle tissue in DMD patients.
  • RAG-17: A clinical-stage, CNS-targeted oligonucleotide therapeutic for amyotrophic lateral sclerosis (ALS). Phase 1 clinical data demonstrated robust SOD1 protein knockdown (~60% CSF SOD1 reduction) and a favorable safety profile, with Phase 2 patient enrollment now fully completed.

Reflecting the global commercial value of its platform, Ractigen entered into a strategic drug discovery and platform licensing collaboration with a publicly listed overseas pharmaceutical company in late 2025, valued at over $3 billion.

Executive & Investor Commentary

Dr. Long-Cheng Li, Founder and Chief Executive Officer of Ractigen Therapeutics:
“Closing this financing round reflects strong capital market validation of Ractigen’s critical leap from pioneering scientific discovery to human clinical proof-of-concept. Over the past decade, the oligonucleotide field achieved tremendous commercial success in liver-targeted silencing, yet extrahepatic delivery and gene activation remained unaddressed global frontiers. Over nearly two decades, we progressed from discovering RNA activation to solving extrahepatic delivery bottlenecks and translating multiple assets into positive human clinical data. Moving forward, Ractigen will continue expanding the boundaries of RNA technology, accelerating clinical translation to deliver transformative, First-in-Class therapeutics to patients worldwide.”

Investment Team, Guozhong Capital:
“Ractigen Therapeutics is dedicated to pioneering next-generation RNA therapeutics globally. Its proprietary extrahepatic delivery platforms breach core bottlenecks across the field. RAG-17 is a pioneering CNS-targeting oligonucleotide therapy with Phase 1 results featured in top-tier peer-reviewed journals, while RAG-01 marks a historic clinical application of saRNA technology in oncology. We look forward to supporting Ractigen as its saRNA platform expands further into genetic, oncologic, and metabolic diseases.”

Haining Wang, Founding Partner of Longmen Capital:
“We have been a long-term believer in Ractigen since our initial investment in 2021, and this marks our third consecutive round of support. Their clinically validated extrahepatic delivery systems and highly differentiated saRNA pipelines create an unrivaled competitive moat. We will continue leveraging our industry and capital market resources to help Ractigen bring saRNA therapies to patients globally.”

About Ractigen Therapeutics

Ractigen Therapeutics is a clinical-stage biopharmaceutical company innovating next-generation RNA therapeutics, with a primary focus on saRNAs developed through its clinically validated RNA activation (RNAa) technology. Leveraging proprietary extrahepatic delivery platforms such as SCAD™, LiCO™, and GLORY™, Ractigen is advancing a robust pipeline addressing severe unmet medical needs in oncology, neurological diseases, and genetic disorders. Committed to scientific excellence and patient-centered innovation, Ractigen strives to transform healthcare through the power of targeted RNA activation and delivery. For more information, visit www.ractigen.com.

 

Bison Bank becomes Portugal’s first MiCA-Regulated Crypto-Asset Service Provider

By
Advertorial Desk
-

Joins a limited group of 30 EU banking institutions to offer Crypto-Asset Services under the new legal framework, bridging traditional finance with the digital asset economy.


LISBON, PORTUGAL – Media OutReach Newswire – 29 July 2026 – Bison Bank has become the first bank in Portugal to operate directly as a Crypto-Asset Service Provider (CASP) under the European MiCA (Markets in Crypto-Assets) regulation, consolidating its position at the forefront of financial innovation. Bison Bank’s CASP activity will be undertaken through the merger of its fully owned subsidiary, Bison Digital Assets (BDA), already approved by the Bank of Portugal. The move follows a journey that began in 2022, when BDA became the first bank-owned Virtual Asset Service Provider (VASP) in Portugal.

“We were pioneers three years ago when we realized the future of banking would involve integrating digital assets. Now, with a clear and solid European framework like MiCA, we are bringing this area into the heart of the bank,” states António Henriques, CEO of Bison Bank. “The CASP license and the merger realize our vision for the bank of the future: a single, regulated entity with the robustness of a bank and the agility of the crypto world.”

Bison Bank’s CASP license, along with the integration of BDA, which in 2025 served approximately 275 clients and handled traded volume of €165 million, positions the bank to accelerate its on-chain strategy. The new CASP structure offers institutional clients simplified access to custody, exchange and advisory services for crypto-assets under a bank-grade compliance and risk management framework. It also supports new products, including the recently launched EUB and USB E-money tokens (stablecoins), and future real-world asset (RWA) tokenization solutions.

This strategy is backed by the bank’s strength. Bison Bank closed 2025 with recurring net profit of €5 million, doubling the previous year, and a CET1 capital ratio of 38.5%, amongamong the highest in European banking. Its leadership in digital assets was recognized with the “Portugal’s Best for Digital Assets” distinction at the Euromoney Global Private Banking Awards 2026.

Bison Bank, S.A. is a Portuguese bank providing Private Banking, Depositary Bank, Corporate Advisory and Digital Assets services to individual and institutional clients, connecting European and global markets.

Bison Digital Assets S.A. is the first Virtual Asset Service Provider licensed by the Bank of Portugal and fully owned by a Portuguese bank, offering digital asset custody and exchange services.

Hashtag: #BisonBank #MiCA #CASP #CryptoAssets #DigitalAssets #DigitalFinance #FinancialInnovation #EuropeanBanking #BankingInnovation #Fintech #Stablecoins #Tokenization #Blockchain #RegulatedCrypto #Portugal

The issuer is solely responsible for the content of this announcement.

iWOW Raises S$15.0 Million For Next Phase of Growth

By
Advertorial Desk
-

More than 10 Institutional investors and Strategic investor

SINGAPORE – Media OutReach Newswire – 29 July 2026 – iWOW Technology Limited is pleased to announce it has completed the placement of 66,667,000 new ordinary shares at a placement price of S$0.225 per Placement Share raising gross proceeds of approximately S$15.0 million.

The Placement strengthens the Group’s balance sheet following the acquisition of The Gentle Group and provides capital for the Group to accelerate its next phase of growth. Broadening the Institutional Shareholder Base

Participants include fund managers under Singapore’s EQDP, Institutional investors include (in alphabetical order) Amova Asset Management, Areca Capital Sdn Bhd, Asdew Acquisitions, Avanda Investment Management Pte. Ltd. (on behalf of certain investment funds and/or managed accounts), Azure Capital, Ginko-AGT Global Growth Fund, ICH Synergrowth Fund, Lion Global Investors Ltd (as investment manager for and on behalf of its clients), Tokio Marine Life Insurance Singapore Pte. Ltd., UOB Asset Management Ltd and Value Partners Hong Kong Limited. Alongside strategic healthcare investors, notably Dr. Lim Cheok Peng, a renowned cardiologist who was Managing Director of IHH Healthcare from 2011 to 2013, who led IHH through its early growth, including its landmark 2012 dual listing on Bursa Malaysia and the Singapore Exchange, which at the time was one of the world’s largest healthcare IPOs.

The strong interest from institutional and strategic investors underscores their confidence in the Group’s growth strategy, and validates its plans to accelerate expansion across its AgeTech, Clinical Nutrition and IoT businesses. Participation by EQDP fund managers will broaden and deepen the Company’s institutional shareholder base and is expected to support greater market visibility, trading liquidity and market depth over time.

As populations age across Asia and other developed markets, iWOW is building an integrated longevity platform centred on three complementary pillars:

* Safety – Buddy of Parents (“BOP”) provides AI-powered monitoring, emergency response and fall detection, enabling seniors to live independently with greater confidence;

* Sustenance – Following the acquisition of The Gentle Group (“TGG”), iWOW offers clinically formulated therapeutic nutrition for seniors managing dysphagia, diabetes, kidney disease and other age-related conditions; and

* Social Connection – Through its collaboration with GetSetUp, iWOW helps older adults stay socially connected, digitally engaged and lifelong learners.

Together, these businesses form a differentiated ecosystem addressing the physical, nutritional and social needs of ageing populations, while strengthening long-term customer engagement.

Hashtag: #agingpopulation #investorrelations

The issuer is solely responsible for the content of this announcement.

About iWOW TECHNOLOGY LIMITED

iWOW Technology Limited is a Singapore Exchange (“SGX“) listed technology company focused on purpose-driven innovation, leveraging its strengths in wireless communications R&D to deliver IoT solutions for rapidly urbanising and ageing societies. iWOW is known for its innovative AgeTech solutions under the Buddy of Parents (“BOP“) brand, which was a recipient of the DBS Foundation Impact Beyond Award

Finloop’s FUIDL is Available on Bybit, Powering Asia’s First RWA End-to-End Ecosystem

By
Advertorial Desk
-

DUBAI, UAE and HONG KONG, July 29, 2026 /PRNewswire/ — Finloop Finance Technology Holding Limited (“Finloop”), an AI-driven Web5 (Web2+Web3) wealth technology platform, announced a new collaboration with Bybit, the world’s second-largest cryptocurrency exchange by trading volume. Its Finloop USD Instant Digital Liquidity token (FUIDL) is officially launched on Bybit, providing institutional and professional investors with on-chain access to an international AAA-rated USD liquidity fund, enabling them to obtain high-quality USD liquidity more conveniently on the blockchain. Bybit enables the share of FUIDL as collateral for trading on its platform.

This collaboration marks a pivotal milestone in Finloop’s development of Asia’s first Real World Asset (RWA) end-to-end ecosystem. The ecosystem delivers end-to-end coverage — from RWA technology support and asset issuance to distribution — representing another innovative breakthrough in the development of compliant digital asset infrastructure in Hong Kong and across Asia.

FUIDL is powered by Finloop, which acts as the tokenization agent providing the tokenization infrastructure and agency services. Its underlying assets are anchored to an AAA-rated USD money market fund, and it supports hourly subscription and redemption, and T+0* (same-day) interest accrual. The underlying USD liquidity fund has received the highest possible ratings from major international agencies: AAAm from Standard & Poor’s (S&P), Aaa-mf from Moody’s and AAAmmf from Fitch. An AAA rating represents the highest rating available for Money Market Funds (MMFs). Bybit users will benefit from same-day settlement across selected tokenized and digital instruments, made possible by Finloop’s market-leading RWA and cash management capabilities, together with the institutional-grade custody and digital asset management platform, ByCustody. This collaboration deeply integrates the stability and operational standards of traditional finance with the speed and transparency of blockchain-based settlement.

Previously, FUIDL has been made available on Fosun Wealth APP under Fosun Wealth Holdings, and multiple compliant virtual asset trading platforms and digital investment platforms in Hong Kong and Singapore. The new offering on Bybit further expands FUIDL’s global institutional reach and underscores Finloop’s continued progress in refining its compliant RWA ecosystem and advancing compliant Web3.0 development in Hong Kong.

Yoyee Wang, Global Head of TradFi and RWA of Bybit, said: “Partnering with Finloop marks a pivotal step in realizing our vision of The New Financial Platform. This collaboration turns that vision into action, merging institutional-grade trust with the efficiency of digital infrastructure of Bybit. By enabling same-day settlement and reinforcing custody standards, we’re not just improving transaction speed; we’re redefining what financial interoperability can look like.”

Cai Hua, CEO of Finloop, said: “This collaboration demonstrates how a wealth technology platform and a digital exchange can work together to achieve instantaneous settlement while meeting high operational and regulatory standards. We are proud to partner with Bybit on this milestone that sets new benchmarks for efficiency and trust in the digital asset space.”

Looking ahead, Finloop will continue to expand FUIDL’s application scenarios and institutional coverage. The company will build an open, innovative and compliant RWA ecosystem, strengthening the bridge between traditional finance (Web2) and digital assets (Web3), and delivering safe, innovative, and efficient wealth technology solutions to global investors.

For more information about FUIDL, please visit:

https://mp.weixin.qq.com/s/mN1SY_UNXzEKrAyV8ZI3mQ
https://www.linkedin.com/feed/update/urn:li:activity:7466045282808434689
https://x.com/FinloopHK/status/2060284153795580006?s=20

*Subject to actual fund arrival time.

Disclaimer:
Bybit and ByCustody are not licensed, approved or regulated by the Hong Kong Securities and Futures Commission and do not service Hong Kong residents.

— End —

About Finloop Finance Technology Holding Limited

Finloop Finance Technology Holding Limited, along with its subsidiaries (collectively referred to as “Finloop”), is an AI-driven global one-stop Web5 (Web2+Web3) wealth technology platform located in Hong Kong. Finloop offers comprehensive wealth management products and technology solutions to various financial institutions. Its offerings include cash management, public funds and private funds, structured products, bonds, insurance, and virtual assets. As a fintech leader in Asia during the Web3 wave, Finloop has focused on bridging physical and digital assets, developing a one-stop RWA technology, issuance and distribution platform to pioneer new growth pathways in the wealth management industry. For more information, visit www.finloop.hk and www.finlooprwa.com 

About Bybit

Bybit is The New Financial Platform.

We believe every person should have access to every financial opportunity on earth. That’s why we’re building the first intelligent platform that connects anyone, anywhere to the world’s finance.

Trusted by more than 80 million users worldwide, Bybit brings together investing, trading, payments, and wealth-building in a single secure and intelligent ecosystem. Through the combination of AI-powered technology, deep global liquidity, robust security, and transparent operations, Bybit makes global finance more accessible, efficient, and empowering for everyone.

Built for everyone. Powered by intelligence. Open to the world.

Bybit is not licensed, approved or regulated by the Hong Kong Securities and Futures Commission and does not service Hong Kong residents.

For more details about Bybit, please visit Bybit Press
For updates, please follow: Bybit’s Communities and Social Media

About ByCustody

ByCustody is an institutional-grade, security-first custody and digital asset management platform. Designed to serve the evolving needs of institutional clients, ByCustody delivers secure and scalable custody solutions backed by enterprise-level security infrastructure.

Powered by MPC (Multi-Party Computation) technology, multi-layer approval workflows, and dedicated on-chain addresses for each client, ByCustody ensures that institutional assets are protected at every layer — from key management to transaction authorization. With a deep understanding of the digital asset landscape, ByCustody empowers institutions to safeguard their assets with confidence, combining robust protection with deep integration into the broader digital asset ecosystem.
ByCustody is not licensed, approved or regulated by the Hong Kong Securities and Futures Commission and does not service Hong Kong residents.
Learn more at: bycustody.com

1...286287288...6,655Page 287 of 6,655